Developments in the treatment of AMD

Eylea (aflibercept) is a new anti-vascular endothelial growth growth factor inhibitor that is as effective and safe as ranibizumab in the treatment of neovascular age-related macular degeneration
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: Featured Articles Source Type: news